Skip to content
10-Q

Quarterly Report

Cadrenal Therapeutics, Inc. CVKD

0001213900-25-073885

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 2.05M sh
Cash And Equivalents Q2 2025 · Aug 6, 2025 $5M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $5.57M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $10.02M
Shares Diluted Q2 2025 · Jun 30, 2025 1.96M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.9M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.07M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.07M sh
Capex Q2 2025 · Jun 30, 2025 $3.25K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$7.67M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$3.37M
Stockholders Equity Q2 2025 · Jun 30, 2025 $4.3M
Stockholders Equity Q2 2025 · Mar 31, 2025 $6.11M
Stockholders Equity Q2 2025 · Dec 31, 2024 $7.44M
Stockholders Equity Q2 2025 · Jun 30, 2024 $3.99M
Stockholders Equity Q2 2025 · Mar 31, 2024 $6.19M
Stockholders Equity Q2 2025 · Dec 31, 2023 $7.69M
Current Liabilities Q2 2025 · Jun 30, 2025 $1.68M
Current Liabilities Q2 2025 · Dec 31, 2024 $2.68M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.68M
Total Liabilities Q2 2025 · Dec 31, 2024 $2.68M
Current Assets Q2 2025 · Jun 30, 2025 $5.97M
Current Assets Q2 2025 · Dec 31, 2024 $10.11M
Total Assets Q2 2025 · Jun 30, 2025 $5.98M
Total Assets Q2 2025 · Dec 31, 2024 $10.12M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.87
Eps Diluted Q2 2025 · Jun 30, 2025 −$3.95
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$2.24
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$3.80
Eps Basic Q2 2025 · Jun 30, 2025 −$1.87
Eps Basic Q2 2025 · Jun 30, 2025 −$3.95
Eps Basic restated Q2 2025 · Jun 30, 2024 −$2.24
Eps Basic restated Q2 2025 · Jun 30, 2024 −$3.80
Sga Expense Q2 2025 · Jun 30, 2025 $2.66M
Sga Expense Q2 2025 · Jun 30, 2025 $4.91M
Sga Expense Q2 2025 · Jun 30, 2024 $1.21M
Sga Expense Q2 2025 · Jun 30, 2024 $2.34M
Rd Expense Q2 2025 · Jun 30, 2025 $1.08M
Rd Expense Q2 2025 · Jun 30, 2025 $2.75M
Rd Expense Q2 2025 · Jun 30, 2024 $1.25M
Rd Expense Q2 2025 · Jun 30, 2024 $1.88M
Net Income Q2 2025 · Jun 30, 2025 −$3.67M
Net Income Q2 2025 · Jun 30, 2025 −$7.51M
Net Income Q2 2025 · Jun 30, 2024 −$2.39M
Net Income Q2 2025 · Jun 30, 2024 −$4.06M
Operating Income Q2 2025 · Jun 30, 2025 −$3.73M
Operating Income Q2 2025 · Jun 30, 2025 −$7.66M
Operating Income Q2 2025 · Jun 30, 2024 −$2.47M
Operating Income Q2 2025 · Jun 30, 2024 −$4.22M